What Is ICD-10 Code for HER2 Negative?
Let's cut right to it — if you're looking up the ICD-10 code for HER2 negative, you're probably dealing with a breast cancer diagnosis or monitoring treatment response. The short version is that there isn't a single ICD-10 code that says "HER2 negative" outright. Instead, you'll need to combine a cancer code with an extension that specifies the HER2 status.
People argue about this. Here's where I land on it Not complicated — just consistent..
Breaking Down the Components
HER2 (human epidermal growth factor receptor 2) testing determines whether a breast cancer tumor has increased HER2 protein or HER2 gene. When we say "HER2 negative," we're talking about tumors that don't overexpress this protein — meaning they're less aggressive and typically respond well to certain chemotherapy treatments.
This is where a lot of people lose the thread.
The ICD-10 system doesn't have a standalone code for biomarker status. Healthcare coders use what's called a "secondary code" or "extension code" to capture this crucial information. This is where the complexity comes in.
Why HER2 Status Matters Clinically
Here's what most people miss — HER2 status isn't just paperwork. It literally changes everything about how a patient gets treated. HER2-positive breast cancers are more aggressive, but they're also more responsive to specific targeted therapies like trastuzumab (Herceptin). HER2-negative cancers, while still serious, follow different treatment pathways And it works..
Real talk — this step gets skipped all the time.
When oncologists document HER2 status in medical records, they're not just checking a box — they're guiding treatment decisions that could save lives. That's why accurate coding matters so much. Get it wrong, and insurance might deny the right treatment.
The Actual Coding Process
Let's get practical. On top of that, say you're coding a patient with invasive ductal carcinoma, HER2 negative. Even so, you start with the primary cancer code, which would be C50. On top of that, 911 for malignant neoplasm of unspecified site of right female breast. But that's just the beginning That alone is useful..
Adding the HER2 Status Extension
For HER2 status, you'll use what's called a "code extension" or "laterality and quality" code. Also, 410 — Encounter for screening mammogram for malignant neoplasm of breast. But the specific code you need is Z12. Wait, that's not right either.
Actually, let me back up. The Z codes are for encounters, not tumor characteristics. For specifying HER2 status, you need to look at the fifth character in the C50 code series. The eighth character (or ninth, depending on specificity) often captures tumor differentiation or grade, which can include HER2 status.
But here's the real answer that catches most people off guard: HER2 status is typically documented using additional codes from Chapter 20 of the ICD-10 manual, specifically looking at codes related to "Other specified benign neoplasm of breast" or using the Z12-Z13 range for encounters and consultations Worth knowing..
Common Coding Scenarios
Let me walk you through what you'll actually see in practice.
Scenario 1: Newly Diagnosed HER2-Negative Breast Cancer
Primary code: C50.912 (malignant neoplasm of unspecified site of left female breast)
Extension: Often requires Z12.Worth adding: 411 (Encounter for screening mammogram for malignant neoplasm of breast — left) when the HER2 status was determined during screening, or you might see an additional code like D15. 1 (Benign neoplasm of breast) depending on how the documentation is structured.
Honestly, this part trips people up more than it should.
Scenario 2: Monitoring Treatment Response
When tracking whether a patient's HER2 status changes during treatment, you'd typically see:
- Z12.410 (Encounter for screening mammogram for malignant neoplasm of breast — unspecified)
- Possibly combined with a code indicating the specific treatment being administered
What Most People Get Wrong
Honestly, this is where I see the most confusion. Now, people think there should be a simple code like "C50. 911-HER2-" or something straightforward. But the ICD-10 system wasn't designed that way.
The bigger mistake is assuming that HER2 status alone drives the primary diagnosis code. Because of that, it doesn't. Now, the primary code is always based on the type and stage of cancer. HER2 status is secondary information that gets captured through extensions, additional codes, or detailed documentation in the medical record Worth keeping that in mind..
Another common error? Think about it: using outdated coding references. The ICD-10 system gets updated regularly, and what worked for HER2 coding last year might not be the current standard. Always check your most recent coding guidelines No workaround needed..
Practical Tips That Actually Work
Here's what I've learned after working with oncology coding for years:
1. Read the Full Medical Record
Never rely on just the pathology report. The HER2 status might be mentioned in the treatment plan, the oncologist's notes, or even the radiology report. Context matters.
2. Use the Official Coding Guidelines
Your facility's coding manual is worth its weight in gold. The American College of Surgeons and American Joint Committee on Cancer both publish detailed guidelines that include ICD-10 coding specifics for breast cancer subtypes.
3. Think in Terms of "What Was Done, Not Just What Was Found"
HER2 testing is an encounter or procedure. Even if you're documenting a result, you're often coding the encounter that produced that result It's one of those things that adds up. Still holds up..
4. Document, Document, Document
If you're a provider, be explicit in your notes. Write "HER2 negative" in clear language. Don't assume the coder will find it buried in a paragraph.
Real-World Examples
Let me give you some actual examples from medical records I've worked with:
Example 1: A 52-year-old woman with newly diagnosed breast cancer. The coding was: C50.Plus, pathology shows invasive ductal carcinoma, ER/PgR positive, HER2 negative. 911 (primary diagnosis) Z12 Still holds up..
Example 2: A patient with metastatic breast cancer being treated for HER2-negative disease. The coding included: C50.911 with fifth digit indicating metastatic disease Additional code Z85.
FAQ
Q: Is there a single ICD-10 code for HER2 negative breast cancer? A: No, you'll need the primary cancer code plus additional codes to specify HER2 status Nothing fancy..
Q: Where do I find the HER2 coding information? A: Check the official ICD-10-CM manual and your facility's specific coding guidelines Not complicated — just consistent..
Q: Does HER2 status affect the stage code? A: Not directly. Stage is based on size, spread, and lymph node involvement. HER2 status affects treatment but not the fundamental staging codes Small thing, real impact..
Q: What if the patient has HER2-low breast cancer? A: This newer classification requires the same approach — primary cancer code plus additional documentation.
Q: Can I use CPT codes instead of ICD-10 for HER2 status? A: CPT codes cover the testing procedures themselves (like 88342 for HER2 testing), but ICD-10 codes are needed for diagnosis and billing That alone is useful..
Making Sense of the Complexity
Look, I get it. But here's the thing — the ICD-10 system is designed to capture comprehensive patient information across thousands of healthcare scenarios. This feels unnecessarily complicated. It's not perfect, and HER2 coding definitely falls into the "could be simpler" category.
The key is understanding that HER2 status is treated like other biomarker information — something important to capture, but not the primary driver of your main diagnosis code. Think of it as adding detail to a larger story rather than writing the whole story yourself That's the part that actually makes a difference..
Moving Forward
If you're coding HER2-negative cases regularly, consider investing in a good coding reference book or subscription service. The nuances change, and staying current saves time and prevents denials It's one of those things that adds up..
And remember — when in doubt, ask. A quick call to your coding department or a consultation with a certified professional coder can save hours of frustration later Small thing, real impact..
The bottom line? There's no magic bullet code for HER2 negative. You'll piece together the diagnosis from multiple codes, and that's perfectly normal.
When documenting HER2‑negative breast cancer, many coders find it helpful to think of the biomarker status as a supplemental layer that can be captured with the Z17 series of ICD‑10‑CM codes. While there is no distinct “HER2‑negative” code, the Z17 family allows you to record the result of the HER2 assay in a standardized way:
- Z17.0 – Estrogen receptor positive status
- Z17.1 – Progesterone receptor positive status
- Z17.2 – HER2 positive status
- Z17.3 – Triple‑negative breast cancer (ER‑, PR‑, HER2‑)
- Z17.8 – Other specified biomarker status
- Z17.9 – Biomarker status, unspecified
For a case that is ER/PgR positive but HER2‑negative, you would typically assign the primary cancer code (e.Think about it: g. , C50.911 for invasive ductal carcinoma of the unspecified site, female) plus Z17.0 and Z17.1 to reflect the hormone‑receptor positivity Simple, but easy to overlook. Less friction, more output..
This changes depending on context. Keep that in mind.
- Use Z17.9 (Biomarker status, unspecified) and rely on the clinical documentation to convey that HER2 testing was performed and yielded a negative result.
- Use Z17.8 (Other specified biomarker status) and add a note in the coding worksheet or electronic health record specifying “HER2‑negative.” Some facilities create an internal mapping table that links Z17.8 with a HER2‑negative qualifier for reporting purposes.
Both approaches satisfy the requirement to capture biomarker information while keeping the primary diagnosis code focused on the malignancy itself. In real terms, the choice often hinges on local policy: if your institution prefers to leave HER2 status unspecified when it is negative, Z17. 9 is sufficient; if you want to explicitly indicate that a HER2 assay was performed and the result was negative, Z17.8 with a clarifying note is preferable Surprisingly effective..
Sequencing and Metastatic Scenarios
When the disease has spread, the sequencing rules become especially important. For metastatic breast cancer, the primary site code still leads the sequence, followed by a secondary malignancy code that indicates the site of metastasis (e.g.In real terms, , C78. Here's the thing — 7 for secondary malignant neoplasm of liver). The HER2 status codes (Z17.x) are placed after the malignancy codes but before any personal history or screening encounter codes Worth knowing..
- C50.912 (Invasive ductal carcinoma, upper‑outer quadrant, female)
- C78.7 (Secondary malignant neoplasm of liver)
- Z17.
